Back to search

Article

Toward precision biomarker RAI therapy of well-differentiated thyroid cancer: linking administered radioactivity (MBq) to a prescribed lesion radiation-absorbed dose (cGy)

2022-10-24

Abstract excerpt

<title>Abstract</title> <p>Purpose To introduce a biomarker-based dosimetry method for radioactive iodine <sup>131</sup>I therapy (RAI) of metastatic differentiated thyroid cancer (mDTC), adapted to the underlying heterogeneity of lesions’ radiation-absorbed dose (RAD) in cGy, and permitting 1) estimates of RAD/lesion with known precision and 2) optimization of patient-specific administered amount of radioactive...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
965e0de1-180d-5a95-801b-1901dd4c0f58
DOI
10.21203/rs.3.rs-2156223/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Toward precision biomarker RAI therapy of well-differentiated thyroid cancer: linking administered radioactivity (MBq) to a prescribed lesion radiation-absorbed dose (cGy)DOI 10.21203/rs.3.rs-2156223/v1
Lesional dosimetry in 131I refractory metastatic differentiated thyroid cancer with BRAFp.V600E or RAS mutation treated with trametinib +/- dabrafenib followed by radioactive iodine.Semantic proximity
Restoring Radioiodine Avidity in Radioiodine-refractory Differentiated Thyroid Cancer With Genotype-guided MAPK Inhibition and Dosimetry-guided Radioiodine.Semantic proximity
Non-Iodine-Avid Disease Is Highly Prevalent in Distant Metastatic Differentiated Thyroid Cancer With Papillary Histology.Semantic proximity
Positive BRAFV600E mutation of primary tumor influences radioiodine avidity but not prognosis of papillary thyroid cancer with lung metastases.Semantic proximity
Clinico-pathological factors and 18 F-FDG PET/CT metabolic parameters for prediction of progression-free survival in Radioiodine Refractory Differentiated Thyroid CarcinomaSemantic proximity
Targeted Therapy in Advanced Thyroid Cancer to Resensitize Tumors to Radioactive Iodine.Semantic proximity
Clinical implementation of PLANET®Dose for dosimetric assessment after [177Lu]Lu-DOTA-TATE: comparison with Dosimetry Toolkit® and OLINDA/EXM® V1.0Semantic proximity
Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer.Semantic proximity
Accuracy and uncertainty analysis of reduced time point imaging effect on time-integrated activity for 177Lu-DOTATATE PRRT in clinical patients and realistic simulationsSemantic proximity
125I seeds implantation for lymph nodes metastasisfrom radioactive iodine-refractory differentiated thyroid carcinoma: A short-term efficacy and dosimetry studySemantic proximity
Thyroid under contrast: Unveiling the effect of radiographic iodinated contrast media on thyroid function testsSemantic proximity
Micronuclei Formation upon Radioiodine Therapy for Well-Differentiated Thyroid Cancer: The Influence of DNA Repair Genes Variants.Semantic proximity
Select a neighboring publication to make it the new centre.